How Aduhelm, an Unproven Alzheimer’s Drug, Got Approved July 20, 2021 Auto Bot Aduhelm (Drug), alzheimer's disease, Biogen Inc, Clinical Trials, Food and Drug Administration, Labeling and Labels (Product), Regulation and Deregulation of Industry, Research, your-feed-healthcare, your-feed-science 0 Though some of its own senior officials said there was little evidence of benefit for patients, the F.D.A. nonetheless greenlighted Biogen’s Aduhelm, or aducanumab.